映恩生物-B 09606.HK 
現價 246.800    升跌 -14.200 (-5.441%)
最後更新: 2025-06-17 04:09:57
日期主要股東
每股
平均價
類型買/賣或涉及
股份數目
變動股數
佔已發行股(%)
目前持股量佔已
發行股(%)
2025-05-09朱忠遠N/A
1312  (S)
N/A
2,599,800(S)
N/A
N/A
16026123(L)
0(S)
18.20(L)
0.00(S)
2025-05-09DualityBio Ltd.N/A
1312  (S)
N/A
2,599,800(S)
N/A
N/A
6500000(L)
0(S)
7.38(L)
0.00(S)
2025-05-09LAV Asset Management (Hong Kong) Limited1213  (L)16,683,221(L)N/A16683221(L)18.95(L)
2025-05-09LAV Fund VI, L.P.1213  (L)11,272,321(L)N/A11272321(L)12.80(L)
2025-05-09LAV GP VI, L.P.1213  (L)11,272,321(L)N/A11272321(L)12.80(L)
2025-05-09LAV Corporate VI GP, Ltd.1213  (L)11,272,321(L)N/A11272321(L)12.80(L)
2025-05-09施毅1213  (L)16,683,221(L)N/A16683221(L)18.95(L)
2025-04-15朱忠遠1701  (L)
1313  (S)
16,026,123(L)
2,599,800(S)
N/A
N/A
16026123(L)
2599800(S)
18.76(L)
3.04(S)
2025-04-15司文1701  (L)1,367,959(L)N/A1367959(L)1.60(L)
2025-04-15張韶壬1701  (L)592,500(L)N/A592500(L)0.69(L)
2025-04-15DualityBio Ltd.1701  (L)
1313  (S)
6,500,000(L)
2,599,800(S)
N/A
N/A
6500000(L)
2599800(S)
7.61(L)
3.04(S)
2025-04-15LAV Fund VI Opportunities, L.P.1701  (L)5,410,900(L)N/A5410900(L)6.33(L)
2025-04-15LAV Asset Management (Hong Kong) Limited1701  (L)16,683,221(L)N/A16683221(L)19.52(L)
2025-04-15LAV GP VI Opportunities, L.P.1701  (L)5,410,900(L)N/A5410900(L)6.33(L)
2025-04-15LAV Corporate VI GP Opportunities, Ltd.1701  (L)5,410,900(L)N/A5410900(L)6.33(L)
*註解 ( L ) - 好倉, ( S ) - 淡倉, ( P ) - 可供借出的股份更新日期:2025-05-14
[第1頁 / 共2頁]
1
資料由AASTOCKS提供 免責聲明